English
Język Polski
Insomnia in the elderly and contemporary treatment methods
Katarzyna Łysiak
Anna Łysiak
Barbara Maziarz
Paulina Przywara
Natalia Bogumiłło
Julia Ignacak
Kinga Ściurka
Mikołaj Borek
Oliwia Grzelak
Abstrakt
Introduction: Insomnia is one of the most common health problems of modern times and the third most common reason for presenting to the primary care doctor after headache and gastrointestinal symptoms.
Aim: The aim of this article is to present current treatments for insomnia in older people over 65 years of age, focusing on cognitive-behavioural therapy complemented by pharmacological treatment.
State of the art brief: The prevalence of insomnia can be as high as 19%. The problem mainly affects older people. It is caused not only by the physiological changes occurring in the process of ageing, but also by the numerous diseases from which seniors suffer. Insufficient sleep can lead to many illnesses or aggravate existing ones, which is particularly dangerous for the aforementioned age group. The treatment of insomnia is based on non-pharmacological methods, which include cognitive-behavioral psychotherapy and sleep hygiene education, and on pharmacological treatment, in which a wide range of drugs are used. In daily practice, mainly benzodiazepines and their derivatives, antidepressants and melatonin are used.
Conclusions: Insomnia is a very significant problem worsening daytime functioning, negatively affecting quality of life. Therefore, appropriate diagnosis of sleep disorders is important, as it may facilitate the identification of the potential cause of the disorder and the introduction of appropriate management.
Inne teksty tego samego autora
- Magdalena Makarewicz, Anna Łysiak, Katarzyna Łysiak, Barbara Maziarz, Evaluation of the effectiveness of platelet-rich plasma therapy in the treatment of osteoarthritis compared to other treatment methods , Prospects in Pharmaceutical Sciences: Tom 22 Nr 4 (2024)
Podobne artykuły
- Magdalena Makarewicz, Anna Łysiak, Katarzyna Łysiak, Barbara Maziarz, Evaluation of the effectiveness of platelet-rich plasma therapy in the treatment of osteoarthritis compared to other treatment methods , Prospects in Pharmaceutical Sciences: Tom 22 Nr 4 (2024)
- Patrycja Słomczyńska, Jakub Młoźniak, Katarzyna Paradowska, LEKI PRZECIWHISTAMINOWE W TERAPII ALERGII I BEZSENNOŚCI , Prospects in Pharmaceutical Sciences: Tom 22 Nr 4 (2024)
- Agnieszka Lembas, Andrzej Załęski, Tomasz Mikuła, Joanna Jabłońska, Szymon Barczak, Barbara Badura, Alicja Wiercińska-Drapało, Differences in the course of hepatocellular carcinoma depending on the DAA treatment , Prospects in Pharmaceutical Sciences: Tom 22 Nr 3 (2024)
- Maciej Bara, Jakub Starownik, Jakub Szydło, Patryk Gryszkiewicz, Jakub Nieznański, Dapagliflozin - new solution in chronic kidney disease treatment , Prospects in Pharmaceutical Sciences: Tom 22 Nr 2 (2024)
- Katarzyna Kozon, Małgorzata Krzyżanowska, Jakub Olszewski, Andrzej Patyra, Spinal muscular atrophy – the effectiveness of treatment and new therapeutic possibilities for selected groups of patients in Poland , Prospects in Pharmaceutical Sciences: Tom 21 Nr 2 (2023)
- Jakub Olszewski, Katarzyna Kozon, Magdalena Sitnik, Katarzyna Herjan, Karolina Mikołap, Bartłomiej Gastoł, Maciej Bara, Piotr Armański, Marcin Sawczuk, Mirikizumab – a new option in treatment of inflammatory bowel diseases , Prospects in Pharmaceutical Sciences: Tom 22 Nr 3 (2024)
- Natalia Cichoń, Dominika Lach, Michał Bijak Bijak, Paulina Rzeźnicka, Joanna Saluk, PODOBIEŃSTWA I RÓŻNICE W TERAPIACH PRZECIWPŁYTKOWYCH W OSTRYCH ZESPOŁACH WIEŃCOWYCH I UDARZE NIEDOKRWIENNYM MÓZGU , Prospects in Pharmaceutical Sciences: Tom 14 Nr 4 (2016)
- Paulina Dąbrowska, Michał Żuber, Michał Dacka, Efficacy and Safety of Bempedoic Acid in Lipid Disorder Therapy: A Review of Clinical Trials , Prospects in Pharmaceutical Sciences: Tom 22 Nr 3 (2024)
- Paulina Oleksa, Daria Żuraw, Kacper Jasiński, Mateusz Sobczyk, Mikołaj Porzak, Alicja Sodolska, Karolina Haczkur-Pawłowska, Drugs and chemical substances inducing diabetes - review of the literature , Prospects in Pharmaceutical Sciences: Tom 22 Nr 2 (2024)
- Agnieszka Sienicka, Krzysztof Kubasik, Agata Pisula, The Glucagon-Like Peptide-1 Analogues therapy in the non-diabetic patients , Prospects in Pharmaceutical Sciences: Tom 21 Nr 1 (2023)
Możesz również Rozpocznij zaawansowane wyszukiwanie podobieństw dla tego artykułu.
Szczegóły
Bibliografia
Statystyki
Autorzy
Zasady cytowania
Cited by / Share
Licencja
Utwór dostępny jest na licencji Creative Commons Uznanie autorstwa 4.0 Międzynarodowe.